about
Regulation of tumour necrosis factor signalling: live or let dieAutophagy-independent functions of UVRAG are essential for peripheral naive T-cell homeostasis.The E3 ubiquitin ligase Mule acts through the ATM-p53 axis to maintain B lymphocyte homeostasis.Antigen receptor-mediated depletion of FOXP3 in induced regulatory T-lymphocytes via PTPN2 and FOXO1.Idh1 protects murine hepatocytes from endotoxin-induced oxidative stress by regulating the intracellular NADP(+)/NADPH ratio.Lymphocyte-derived ACh regulates local innate but not adaptive immunityBRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival.Reduced type I interferon production by dendritic cells and weakened antiviral immunity in patients with Wiskott-Aldrich syndrome protein deficiencyPhosphorylation of CARMA1 by HPK1 is critical for NF-kappaB activation in T cells.Cellular senescence or EGFR signaling induces Interleukin 6 (IL-6) receptor expression controlled by mammalian target of rapamycin (mTOR).K48-linked KLF4 ubiquitination by E3 ligase Mule controls T-cell proliferation and cell cycle progression.Mitochondrial cell death effectors.c-FLIPR, a new regulator of death receptor-induced apoptosis.HDAC inhibitors trigger apoptosis in HPV-positive cells by inducing the E2F-p73 pathway.TNF and ROS Crosstalk in Inflammation.Enterohaemorrhagic, but not enteropathogenic, Escherichia coli infection of epithelial cells disrupts signalling responses to tumour necrosis factor-alpha.Lack of T-cell receptor-induced signaling is crucial for CD95 ligand up-regulation and protects cutaneous T-cell lymphoma cells from activation-induced cell death.Activation or suppression of NFkappaB by HPK1 determines sensitivity to activation-induced cell death.MALT1 is an intrinsic regulator of regulatory T cells.RAIDD Mediates TLR3 and IRF7 Driven Type I Interferon Production.Deficiency of MALT1 paracaspase activity results in unbalanced regulatory and effector T and B cell responses leading to multiorgan inflammation.The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells.Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression.Toso regulates differentiation and activation of inflammatory dendritic cells during persistence-prone virus infection.IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis.The c-FLIP-NH2 terminus (p22-FLIP) induces NF-kappaB activation.Histone deacetylase inhibitor-induced sensitization to TNFalpha/TRAIL-mediated apoptosis in cervical carcinoma cells is dependent on HPV oncogene expression.Tumor Necrosis Factor-Mediated Survival of CD169+ Cells Promotes Immune Activation during Vesicular Stomatitis Virus Infection.Survival of the fittest: Cancer challenges T cell metabolism.Energy-sensitive regulation of Na+/K+-ATPase by Janus kinase 2.B-Cell Metabolic Remodeling and Cancer.Reactive Oxygen Species: Involvement in T Cell Signaling and Metabolism.In vitro generated human memory-like T cells are CD95 type II cells and resistant towards CD95-mediated apoptosis.Sustained JNK signaling by proteolytically processed HPK1 mediates IL-3 independent survival during monocytic differentiation.The TNF Family of Ligands and Receptors: Communication Modules in the Immune System and BeyondCaspase-cleaved HPK1 induces CD95L-independent activation-induced cell death in T and B lymphocytesGlutathione Primes T Cell Metabolism for InflammationGuidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)Protection from EAE in DOCK8 mutant mice occurs despite increased Th17 cell frequencies in the peripheryCholine acetyltransferase-expressing T cells are required to control chronic viral infection
P50
Q28262381-6A927D8E-87A2-447E-B996-E77023F7D321Q35038065-8608801E-FB51-4852-8C00-5683E6EE9599Q35679564-81D53CEF-C520-4D93-BE5D-CF063EC1DDFFQ36250847-592A3056-DC63-40EF-8FD6-6E160D461801Q36288338-65D360DA-001B-4B94-B81C-E246E6345F49Q36567979-9DAFF61B-38B8-41CE-BD29-30D90972F6FCQ37055527-3A7FCBD6-D65D-4441-8C68-B07CA4F0A7A0Q37132013-A684FE96-B93B-4BB9-ADFC-5EB8859FFF0CQ37321154-2653A9E9-02DF-49ED-8B6B-9DF426BA2B84Q37492314-845BC589-F905-452C-8F83-2F6964CADE13Q37591368-B28FCF5C-D44E-43CB-BEA4-C9AAF39EB162Q37613265-08CA7CB9-3F46-4B6D-A259-241082E7F79DQ38330819-5AEBDF27-955C-4B6B-946E-5E3B6ED1EF4BQ38342582-074FE883-CF1A-47D4-BF6D-4A64C73AE28AQ38704621-E4E69BB7-08C1-4869-B844-242A19AC3C86Q39498949-9BA527B6-1631-43C3-99A2-4590387DD988Q39980345-F93D5D6A-295B-4036-A330-59F06785F242Q40341387-9891BAD1-23E0-45CD-A30E-345F5BD47DADQ40503533-D8E13DA8-ABD3-4247-B3EE-6BD892579A00Q40547627-8FE9AF19-C645-46E8-A811-561607D2C0FFQ41240873-9BB4C81E-09D8-4A2D-AEDD-7F32222A1F0BQ41522425-D9245F04-7912-4BE9-9474-2F6AFD806310Q41522811-17C2D7FC-950D-4B65-8F7B-619A356F7FEDQ41725811-17C362E8-EAE9-401A-98CE-B0B02448C118Q42136819-6E23943C-7B63-482F-B8F0-FC3DDB9A7CF7Q42772785-7BCA89C2-A010-4C6F-8217-789922A67F21Q45001641-C4835ED4-2CE9-46A4-A374-8D4842EF5D7CQ45324796-C3B27A20-68FD-45FE-BB52-6B1ADC880E0BQ46273840-FFF5A74A-9A69-43E9-A74B-D4CC8968D95BQ48613326-4327EA64-6FCE-405C-BCCD-EFF4F9A5F605Q49835162-5326B34F-FB14-48ED-A2C4-97C1D667044EQ49917484-26FE7D03-0B3A-4CAE-8722-7578A18F0773Q51978473-2B4C02E7-7BDE-479C-8407-308938DFA972Q53595082-8C804D5B-29D4-453F-8841-5E8DD5B2AA03Q57785317-2603C93A-88B6-4EB1-A627-9EFE2A3F15A2Q80825543-BDB6CCF9-411B-417A-9AFF-9B125A0FA87AQ88360029-E95CB557-AF2C-402F-951D-A1574DA7E699Q90841989-8C9E8217-1CB2-4349-A122-D05E31AB186AQ91391771-4CB477CB-0D01-452F-8136-14536438A676Q91410079-0B4B355F-D2A0-48D4-92DA-31F1303CAA50
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Dirk Brenner
@ast
Dirk Brenner
@en
Dirk Brenner
@es
Dirk Brenner
@nl
Dirk Brenner
@sl
type
label
Dirk Brenner
@ast
Dirk Brenner
@en
Dirk Brenner
@es
Dirk Brenner
@nl
Dirk Brenner
@sl
prefLabel
Dirk Brenner
@ast
Dirk Brenner
@en
Dirk Brenner
@es
Dirk Brenner
@nl
Dirk Brenner
@sl
P106
P1153
8920285000
P21
P31
P496
0000-0001-8979-1045